Medy-Tox (XKRX:086900) Long-Term Capital Lease Obligation : ₩1,226 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Long-Term Capital Lease Obligation?

Medy-Tox's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩1,226 Mil.

Medy-Tox's quarterly Long-Term Capital Lease Obligation increased from Jun. 2023 (₩673 Mil) to Sep. 2023 (₩828 Mil) and increased from Sep. 2023 (₩828 Mil) to Dec. 2023 (₩1,226 Mil).

Medy-Tox's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (₩325 Mil) to Dec. 2022 (₩336 Mil) and increased from Dec. 2022 (₩336 Mil) to Dec. 2023 (₩1,226 Mil).

Medy-Tox Long-Term Capital Lease Obligation Historical Data

The historical data trend for Medy-Tox's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Long-Term Capital Lease Obligation Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

371.36

309.67

324.75

335.95

1,225.84

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															335.95	-	673.24	828.21	1,225.84

Medy-Tox (XKRX:086900) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Medy-Tox Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines